08
Feb
<
But some voices in the scientific field have warned of the side effects that may involve the blockade of this gene
A treatment that blocks the Myc regulatory gene, involved in tissue regeneration, might be effective against cancer, according to research published by the British science journal Nature.
The Myc gene is found in healthy cells but, when a tumor, its over expression is common-genetic-information overload, a fact that served as a starting point for researchers from the University of California, San Francisco (USA), as considered a possible target in the fight against cancer.
To prove their hypothesis, the team led by Gerard Evans, used in laboratory mice that had been induced lung cancer and then they inhibit the action of this gene by treatment.
Thus,
scientists were able to transmit the tumor both in rodents that were in the early stages of the disease as those who already suffered from advanced stage.
Inhibitor therapy slowed cancer even in those mice was not over expressed Myc, which expands the possibilities of such treatment.
Some voices in the scientific field have warned of the side effects that may involve the blockade of this gene, which acts in the regeneration of tissues such as skin and bone marrow.
The research team acknowledges that the mice, but showed no apparent signs of ill health or suffering upon receiving the therapy showed less activity in the bone marrow and decreased production of white blood cells and anemia.
But experts say these side effects disappeared within two weeks, over what they consider viable and useful to develop treatments that act against this gene.
Leave a Reply